219 related articles for article (PubMed ID: 15610657)
21. Novel immune-based treatment strategies for chronic lymphocytic leukemia.
Wierda WG; Kipps TJ; Keating MJ
J Clin Oncol; 2005 Sep; 23(26):6325-32. PubMed ID: 16155015
[TBL] [Abstract][Full Text] [Related]
22. Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia.
Kay NE
Semin Hematol; 2006 Apr; 43(2 Suppl 2):S50-4. PubMed ID: 16549115
[TBL] [Abstract][Full Text] [Related]
23. Chronic lymphocytic leukaemia (CLL): treatment.
Rozman C; Montserrat E
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():159-61. PubMed ID: 2469508
[No Abstract] [Full Text] [Related]
24. Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma.
Tam CS; Wolf M; Prince HM; Januszewicz EH; Westerman D; Lin KI; Carney D; Seymour JF
Cancer; 2006 Jun; 106(11):2412-20. PubMed ID: 16649223
[TBL] [Abstract][Full Text] [Related]
25. Current status and future directions of clinical trials in chronic lymphocytic leukemia.
Nerenstone SR; Archer JI; Cheson BD
Oncology (Williston Park); 1987 Oct; 1(8):31-40, 44. PubMed ID: 3079490
[TBL] [Abstract][Full Text] [Related]
26. Management of advanced chronic lymphocytic leukemia.
Cao TM; Coutre SE
Curr Hematol Rep; 2003 Jan; 2(1):65-72. PubMed ID: 12901156
[TBL] [Abstract][Full Text] [Related]
27. Emerging therapies for patients with advanced chronic lymphocytic leukaemia.
Delgado J; Briones J; Sierra J
Blood Rev; 2009 Sep; 23(5):217-24. PubMed ID: 19643519
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic management of chronic lymphocytic leukaemia: state of the art and future perspectives.
García-Escobar I; Sepúlveda J; Castellano D; Cortés-Funes H
Crit Rev Oncol Hematol; 2011 Oct; 80(1):100-13. PubMed ID: 21146422
[TBL] [Abstract][Full Text] [Related]
29. New aspects of the treatment of chronic lymphocytic leukemia.
Faderl S; Wierda W; Keating MJ
Curr Hematol Malig Rep; 2006 Dec; 1(4):251-7. PubMed ID: 20425320
[TBL] [Abstract][Full Text] [Related]
30. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
[TBL] [Abstract][Full Text] [Related]
31. New agents for the treatment of acute myeloid leukemia.
Tallman MS
Best Pract Res Clin Haematol; 2006; 19(2):311-20. PubMed ID: 16516128
[TBL] [Abstract][Full Text] [Related]
32. Recent progress in the management of chronic lymphocytic leukemia.
Robak T
Cancer Treat Rev; 2007 Dec; 33(8):710-28. PubMed ID: 17904294
[TBL] [Abstract][Full Text] [Related]
33. Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?
Ahmadi T; Schuster SJ
J Clin Oncol; 2009 Feb; 27(4):479-80. PubMed ID: 19075263
[No Abstract] [Full Text] [Related]
34. Emerging therapeutic options for B-cell disorders: idiopathic thrombocytopenic purpura and chronic lymphocytic leukemia.
Goodrich A
Clin J Oncol Nurs; 2007 Feb; 11(1 Suppl):23-36. PubMed ID: 17474175
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of a patient with chronic lymphocytic leukaemia (CLL) presenting with bony metastases with aggressive antibody and chemotherapy.
Narayan H; Bandyopadhyay D; Schmidt K; Chachlani N; Hughes M; Paneesha S; Rose P; Borg A
Clin Lab Haematol; 2005 Dec; 27(6):405-8. PubMed ID: 16307545
[TBL] [Abstract][Full Text] [Related]
36. Minimal residual disease in chronic lymphocytic leukaemia: is it ready for primetime?
Nabhan C; Coutré S; Hillmen P
Br J Haematol; 2007 Feb; 136(3):379-92. PubMed ID: 17129223
[TBL] [Abstract][Full Text] [Related]
37. Autologous stem cell transplantation for chronic lymphocytic leukemia.
Dreger P; Brand R; Michallet M
Semin Hematol; 2007 Oct; 44(4):246-51. PubMed ID: 17961723
[TBL] [Abstract][Full Text] [Related]
38. Bendamustine in the treatment of chronic lymphocytic leukemia.
Knauf W
Expert Rev Anticancer Ther; 2009 Feb; 9(2):165-74. PubMed ID: 19192955
[TBL] [Abstract][Full Text] [Related]
39. Pentostatin in chronic lymphocytic leukemia.
Sauter C; Lamanna N; Weiss MA
Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1217-22. PubMed ID: 18721115
[TBL] [Abstract][Full Text] [Related]
40. Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.
Byrd JC; Gribben JG; Peterson BL; Grever MR; Lozanski G; Lucas DM; Lampson B; Larson RA; Caligiuri MA; Heerema NA
J Clin Oncol; 2006 Jan; 24(3):437-43. PubMed ID: 16344317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]